REDUCEDT+7
Artiva Biotherapeutics Inc · NASDAQ
−10,340 sh · $70.7K
Filed 6 Oct 2026SEC Form 4view source
- ACQUIREDStale
Artiva Biotherapeutics Inc · NASDAQ
+40,000 sh
Filed 11 Sept 2026SEC Form 4view source - REDUCEDStale
Artiva Biotherapeutics Inc · NASDAQ
−10,366 sh · $115.6K
Filed 4 Sept 2026SEC Form 4view source